Initial Combination Therapy for Low-Risk PAH Patients

Created using ChatSlide

Explore the pivotal AMBITION trial and its role in advancing Pulmonary Arterial Hypertension (PAH) treatment protocols. This training session delves into trial data, using risk tools like REVEAL 2.0 and PHORA to assess primary and secondary endpoints with advanced statistical methods. Analyze patient outcomes, side effect impacts, and strategic treatment implications. Gain critical insights through a comparative study analysis and understand the economic and prospective research needs....